(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.15%) $0.928
(0.11%) $10.85
(0.01%) $0.792
(-0.08%) $92.51
Live Chart Being Loaded With Signals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia...
Stats | |
---|---|
Today's Volume | 1.44M |
Average Volume | 310 354 |
Market Cap | 559.01M |
EPS | HKD0 ( 2023-08-28 ) |
Last Dividend | HKD0.00260 ( 2023-06-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -26.00 |
ATR14 | HKD0 (0.00%) |
Tianda Pharmaceuticals Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Tianda Pharmaceuticals Financials
Annual | 2022 |
Revenue: | HKD546.69M |
Gross Profit: | HKD251.52M (46.01 %) |
EPS: | HKD-0.0254 |
Q1 | 2023 |
Revenue: | HKD303.48M |
Gross Profit: | HKD155.10M (51.11 %) |
EPS: | HKD-0.00190 |
Q2 | 2021 |
Revenue: | HKD122.87M |
Gross Profit: | HKD90.25M (73.46 %) |
EPS: | HKD0.000365 |
Q1 | 2021 |
Revenue: | HKD122.87M |
Gross Profit: | HKD90.25M (73.46 %) |
EPS: | HKD0.000365 |
Financial Reports:
No articles found.
Tianda Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0112 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.00260 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00450 | 2010-07-23 |
Last Dividend | HKD0.00260 | 2023-06-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.0530 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.84 | -- |
Div. Sustainability Score | 6.04 | |
Div.Growth Potential Score | 1.971 | |
Div. Directional Score | 4.01 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2342.HK | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
1336.HK | Ex Dividend Knight | 2023-07-06 | Annually | 0 | 0.00% | |
0392.HK | Ex Dividend Junior | 2023-09-22 | Semi-Annually | 0 | 0.00% | |
6127.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1883.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
0921.HK | Ex Dividend Knight | 2023-07-10 | Sporadic | 0 | 0.00% | |
0057.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
2778.HK | Ex Dividend Junior | 2023-09-15 | Semi-Annually | 0 | 0.00% | |
1461.HK | Ex Dividend Junior | 2023-06-20 | Sporadic | 0 | 0.00% | |
0548.HK | Ex Dividend Junior | 2023-05-19 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0999 | 1.500 | -1.999 | -3.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.0502 | 1.200 | -1.673 | -2.01 | [0 - 0.3] |
returnOnEquityTTM | -0.0789 | 1.500 | -1.988 | -2.98 | [0.1 - 1] |
payoutRatioTTM | -0.323 | -1.000 | -3.23 | 3.23 | [0 - 1] |
currentRatioTTM | 1.540 | 0.800 | 7.30 | 5.84 | [1 - 3] |
quickRatioTTM | 1.342 | 0.800 | 6.81 | 5.45 | [0.8 - 2.5] |
cashRatioTTM | 0.939 | 1.500 | 5.90 | 8.84 | [0.2 - 2] |
debtRatioTTM | 0.130 | -1.500 | 7.84 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -9.37 | 1.000 | -4.58 | -4.58 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0368 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0255 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.225 | -1.500 | 9.10 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.460 | 1.000 | 5.67 | 5.67 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.128 | 1.000 | -4.57 | -4.57 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.561 | 1.000 | 8.00 | 8.00 | [0.2 - 2] |
assetTurnoverTTM | 0.502 | 0.800 | 9.98 | 7.99 | [0.5 - 2] |
Total Score | 6.04 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -10.23 | 1.000 | -1.135 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0789 | 2.50 | -1.278 | -2.98 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0255 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.000 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0368 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | -0.323 | 1.500 | -3.23 | 3.23 | [0 - 1] |
pegRatioTTM | -0.619 | 1.500 | -7.46 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.145 | 1.000 | 8.88 | 0 | [0.1 - 0.5] |
Total Score | 1.971 |
Tianda Pharmaceuticals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators